Protocol Compliance [GxP / QC / QA]

posted by Dr.Sridhar – 2010-04-03 13:04 (5928 d 21:36 ago) – Posting: # 5007
Views: 7,000

Dear Raghavendra,

It will be better to safety analysis to be on safer side because this will prove that subject lost to follow up was due to his personal problems or not due to any Adverse event with your drug.

And you can also file an protocol deviation for same with proper explanation.

Regards,
Dr.Sridhar


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
354 visitors (0 registered, 354 guests [including 11 identified bots]).
Forum time: 10:41 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5